worldwid
impact
predict
becom
fifth
lead
burden
world
health
copd
caus
million
death
worldwid
year
elderli
especi
subject
health
effect
copd
copd
primari
contribut
diagnosi
hospit
patient
year
age
medicar
health
care
expenditur
time
higher
elderli
patient
copd
compar
agematch
person
without
condit
versu
mean
perperson
direct
medic
expenditur
among
person
copd
year
age
dollar
result
two
larg
epidemiolog
studiesth
third
nation
health
nutrit
examin
survey
estudio
de
la
epoc
en
surveynot
highest
copd
occurr
rate
elderli
current
smoker
older
age
group
note
symptomat
copd
larg
populationbas
survey
recent
trend
smoke
habit
preval
copd
higher
women
men
preval
societ
impact
copd
predict
increas
feenstra
et
al
project
dynam
lifet
model
loss
life
year
due
copd
netherland
increas
compar
baselin
year
health
care
cost
due
copd
predict
increas
period
elderli
patient
moder
sever
copd
experi
acut
exacerb
airway
diseas
present
risk
acut
respiratori
failur
although
definit
acut
exacerb
vari
recent
consensu
statement
defin
exacerb
presenc
one
cardin
symptom
increas
dyspnea
increas
sputum
volum
increas
sputum
purul
use
definit
sever
acut
exacerb
grade
winnepeg
criteria
box
intern
work
group
pulmonari
physician
recommend
comprehens
definit
acut
exacerb
group
contend
requir
symptom
bronchiti
cough
purul
sputum
underidentifi
patient
acut
exacerb
propos
definit
exacerb
sustain
worsen
patient
condit
stabl
state
beyond
normal
daytoday
variat
acut
onset
necessit
chang
regular
medic
patient
underli
copd
sever
acut
exacerb
use
definit
grade
level
health
care
use
see
box
regardless
definit
use
elderli
patient
advanc
copd
experi
averag
two
three
acut
exacerb
year
episod
last
day
pathophysiolog
acut
exacerb
copd
incomplet
understood
increas
concentr
proinflammatori
mediat
inflammatori
cell
expector
sputum
bronchoalveolar
lavag
sampl
tissu
biopsi
lung
exacerb
demonstr
presenc
inflamm
within
surround
airway
acut
exacerb
inflamm
assum
characterist
allerg
respons
increas
eosinophil
upregul
rant
regul
upon
activ
normal
tcell
express
secret
epithelium
subepithelium
common
trigger
acut
exacerb
copd
includ
airway
infect
particul
air
pollut
environment
temperatur
chang
although
patient
clinic
appar
etiolog
factor
patient
acut
exacerb
commonli
associ
condit
congest
heart
failur
pulmonari
emboli
extrapulmonari
infect
bronchial
infect
import
caus
acut
exacerb
bacteri
atyp
bacteri
viral
pathogen
commonli
identifi
microb
box
although
lower
airway
patient
copd
harbor
mix
flora
bacteria
airway
inflamm
bacteri
load
increas
acut
exacerb
observ
suggest
new
virul
bacteri
strain
introduc
airway
popul
colon
bacteria
promot
inflammatori
respons
trigger
acut
exacerb
box
criteria
grade
sever
acut
exacerb
chronic
bronchiti
american
colleg
chest
physiciansamerican
colleg
physiciansamerican
societi
intern
medicin
guidelin
mild
exacerb
presenc
one
cardin
symptom
increas
dyspnea
increas
sputum
volum
increas
sputum
purul
addit
upper
respiratori
infect
within
past
day
fever
caus
increas
wheez
cough
rise
baselin
respiratori
rate
heart
rate
moder
exacerb
presenc
two
three
cardin
symptom
exacerb
sever
exacerb
presenc
three
cardin
symptom
exacerb
intern
consensu
group
mild
exacerb
patient
increas
need
medicaiton
manag
patient
normal
environ
moder
exacerb
patient
increas
need
medic
feel
need
seek
addit
medic
assist
sever
exacerb
patientcaregiv
recogn
obviou
rapid
deterior
condit
requir
hospit
copd
ten
patient
acut
exacerb
infect
two
pathogen
among
atyp
pathogen
chlamydia
pneumonia
estim
account
acut
exacerb
exacerb
result
admiss
icu
viral
bronchiti
found
patient
acut
exacerb
requir
icu
admiss
one
recent
studi
indic
exacerb
due
viral
bronchiti
sever
compar
nonvir
exacerb
associ
longer
time
recoveri
viral
particl
also
shown
produc
latent
infect
augment
inflammatori
respons
subsequ
stimul
airway
reactiv
elderli
patient
acut
exacerb
airway
diseas
experi
increas
resist
expiratori
airflow
increas
work
breath
caus
respiratori
muscl
fatigu
shown
spirometr
flowvolum
loop
fig
normal
individu
breath
rest
expiratori
air
flow
well
within
limit
maxim
flow
rate
capac
healthi
person
therefor
reach
maxim
flow
rate
even
vigor
exercis
contrast
patient
moder
sever
copd
tidal
volum
flow
rate
acut
exacerb
patient
attempt
increas
minut
ventil
increas
tidal
volum
limit
low
maxim
flow
rate
patient
respond
increas
respiratori
rate
decreas
time
avail
expiratori
empti
alveoli
narrow
airway
patient
experi
progress
trap
air
within
lung
dynam
hyperinfl
increas
work
breath
eventu
increas
fatigu
prevent
patient
meet
ventilatori
demand
caus
hypercapn
respiratori
failur
base
pathophysiolog
respiratori
failur
copd
manag
center
decreas
airway
resist
decreas
work
breath
unload
ventilatori
demand
respiratori
muscl
treat
prevent
respiratori
muscl
fatigu
therapeut
recommend
manag
elderli
patient
icu
acut
exacerb
copd
deriv
expert
consensu
pauciti
larg
prospect
random
trial
initi
manag
includ
supplement
oxygen
nasal
cannula
face
mask
control
oxygen
flow
oxygen
flow
titrat
goal
achiev
oxygen
satur
partial
pressur
arteri
oxygen
mm
hg
oxygen
flow
monitor
prevent
hypercapnia
result
effect
supplement
oxygen
increas
deadspac
ventil
ventilationperfus
mismatch
inhal
bronchodil
promot
bronchodil
achiev
increas
fev
fvc
within
hour
fourteen
random
trial
support
conclus
shortact
bagonist
albuterol
levalbuterol
pirbuterol
bitolterol
fenoterol
metaproterenol
terbutalin
anticholinergictyp
inhal
bronchodil
ipratropium
bromid
similar
efficaci
manag
acut
exacerb
effect
parenter
bronchodil
faster
onset
action
bagonist
lower
frequenc
advers
effect
anticholinerg
drug
determin
drug
select
individu
patient
differ
exist
administr
inhal
bronchodil
meter
dose
inhal
spacer
jet
nebul
initi
therapi
usual
start
nebul
howev
critic
ill
patient
acut
respiratori
distress
may
experi
difficulti
use
meter
dose
inhal
patient
switch
meter
dose
inhal
mdi
therapi
soon
regain
abil
synchron
breath
mdi
devic
although
clinician
often
combin
inhal
shortact
bagonist
ipratropium
bromid
patient
acut
exacerb
exist
data
demonstr
margin
benefit
combin
therapi
recent
evidencebas
consensu
statement
american
colleg
chest
physician
american
colleg
physiciansamerican
societi
intern
medicin
recommend
initi
treatment
ipratropium
bromid
addit
shortact
badrenerg
agonist
patient
respond
maxim
dose
anticholinerg
drug
expert
recommend
revers
approach
begin
bagonist
drug
ideal
dose
schedul
shortact
bagonist
ipratropium
bromid
establish
high
dose
bagonist
may
caus
tachyarrythmia
tremor
idiosyncrat
bronchoconstrict
tachyphylaxi
data
support
use
parenter
aminophyllin
critic
ill
elderli
patient
hospit
icu
acut
exacerb
copd
emerg
depart
set
shortterm
use
aminophyllin
demonstr
either
chang
measur
outcom
decreas
risk
subsequ
hospit
high
rate
advers
effect
patient
treat
aminophyllin
combin
question
benefit
markedli
decreas
use
drug
icu
recent
guidelin
recommend
use
aminophyllin
acut
exacerb
copd
role
bacteri
infect
caus
exacerb
airway
diseas
support
use
antibiot
although
studi
perform
critic
ill
patient
cumul
find
sever
studi
howev
demonstr
benefit
patient
acut
exacerb
sever
exacerb
mark
presenc
purul
sputum
studi
antibiot
efficaci
acut
exacerb
perform
era
multidrug
resist
bacteria
appropri
select
antibiot
critic
ill
patient
remain
unclear
firstlin
antibiot
doxycyclin
trimethoprimsulfamethoxazol
amoxacillin
recommend
gener
ambulatori
patient
acut
exacerb
mani
clinician
howev
use
newer
class
broadspectrum
antibiot
hospit
patient
demonstr
superior
newer
drug
await
random
control
trial
pend
result
studi
reason
recommend
newer
macrolid
azithromycin
clarithromycin
newer
cephalosporin
cefpodoxim
cefprozil
amoxicillinclavulan
doxycyclin
hospit
patient
critic
ill
patient
patient
risk
factor
poor
outcom
baselin
fev
predict
comorbid
condit
three
exacerb
last
month
benefit
newer
fluoroquinolon
levofloxacin
gatifloxacin
moxifloxacin
risk
gramneg
organ
pseudomona
aeruginosa
suspect
baselin
fev
predict
underli
bronchiectasi
multipl
cours
antibiot
ciprofloxacin
prefer
antibiot
prospect
random
control
trial
demonstr
system
corticosteroid
improv
outcom
patient
acut
exacerb
demonstr
rapid
improv
measur
airflow
ga
exchang
respiratori
symptom
decreas
treatment
failur
rate
relaps
rate
exist
studi
use
differ
treatment
regimen
optim
dose
durat
corticosteroid
unknown
largest
studi
date
hospit
patient
howev
use
methylprednisolon
mg
iv
everi
hour
day
follow
corticosteroid
taper
schedul
use
oral
prednison
patient
treat
week
corticosteroid
well
patient
treat
week
hyperglycemia
major
complic
corticosteroid
therapi
hospit
patient
acut
exacerb
studi
support
use
expector
mucolyt
agent
mucokinet
drug
manag
critic
ill
patient
copd
physic
therapi
postur
drainag
chest
clappag
may
acut
worsen
respiratori
function
without
provid
measur
benefit
posit
pressur
ventil
unload
respiratori
muscl
prevent
treat
respiratori
muscl
fatigu
ventilatori
support
provid
tightfit
face
mask
form
noninvas
posit
pressur
ventil
nippv
tracheal
intub
mechan
ventil
nippv
shown
random
control
trial
provid
benefit
subset
patient
acut
respiratori
failur
decreas
need
intub
shorten
hospit
stay
increas
surviv
mani
benefit
occur
lower
risk
pneumonia
nippv
compar
intub
mechan
ventil
rational
nippv
deriv
respiratori
muscl
unload
occur
ventilatori
support
allow
patient
maintain
adequ
breath
underli
airway
problem
revers
hospit
elderli
patient
present
respiratori
distress
acut
exacerb
evalu
nippv
patient
admit
even
mild
respiratori
acidosi
may
benefit
nippv
unfortun
hospit
patient
candid
nippv
poor
candid
nippv
includ
patient
cardiovascular
instabl
respiratori
arrest
limit
abil
clear
increas
airway
secret
poor
airway
control
agit
sever
encephalopathi
glascow
coma
scale
uncooper
upper
gastrointestin
bleed
upper
airway
obstruct
high
risk
aspir
facial
featur
interfer
proper
fit
face
mask
recent
studi
demonstr
use
nippv
requir
nurs
respiratori
therapist
time
compar
intub
mechan
ventil
basic
principl
initi
nippv
list
box
key
success
applic
nippv
patient
copd
thought
individu
care
cautiou
titrat
posit
pressur
support
patient
sever
respiratori
failur
candid
nippv
requir
intub
mechan
ventil
ventilatori
support
provid
increas
minut
ventil
correct
abnorm
ga
exchang
unload
respiratori
muscl
allow
recoveri
respiratori
muscl
fatigu
identifi
appropri
patient
review
equip
patient
explain
care
fit
appropriates
mask
adjust
ventil
initi
low
pressur
cm
h
inspir
cm
h
expir
patient
hold
mask
place
ask
patient
report
comfort
level
adjust
ventil
pressur
accordingli
adjust
oxygen
flow
rate
meet
target
oxygen
satur
level
adjust
mask
avoid
leak
monitor
patient
frequent
coach
breath
pattern
gradual
increas
inspiratori
pressur
maxim
relief
dyspnea
although
specif
techniqu
mechan
ventil
beyond
scope
present
articl
gener
principl
center
avoid
dynam
hyperinfl
patient
acut
respiratori
failur
increas
airflow
limit
slow
expiratori
airflow
delay
alveolar
empyt
mechan
ventil
larg
tidal
volum
rapid
respiratori
rate
produc
dynam
hyperinfl
rais
alveolar
pressur
end
expir
term
autoposit
end
expiratori
pressur
autopeep
autopeep
interfer
patient
abil
spontan
trigger
ventil
creat
discomfort
may
requir
heavi
sedat
compromis
cardiac
function
strategi
avoid
dynam
hyperinfl
includ
use
lower
tidal
volum
increas
inspiratori
flow
rate
moder
respiratori
rate
use
appliedpeep
lower
level
measur
autopeep
may
enhanc
ventil
trigger
promot
patient
comfort
detail
review
ventil
strategi
patient
copd
review
elsewher
patient
intub
respiratori
failur
due
copd
improv
within
first
hour
care
undergo
success
wean
earli
extub
goal
patient
revers
bronchospasm
rest
fatigu
ventilatori
muscl
prevent
dynam
hyperinfl
avoid
oversed
associ
increas
risk
nosocomi
pneumonia
delay
wean
patient
requir
mechan
ventil
longer
hour
increas
risk
death
longterm
mechan
ventil
although
prospect
random
data
support
role
earli
tracheotomi
ventilatordepend
patient
copd
found
tracheotomi
valuabl
promot
patient
comfort
decreas
need
analges
sed
improv
nutrit
articul
speech
patient
mobil
factor
combin
improv
access
lower
airway
pulmonari
toilet
decreas
airway
resist
wean
trial
promot
success
wean
evalu
patient
tracheotomi
day
intub
success
extub
appear
unlik
next
sever
day
proceed
tracheotomi
promot
patient
comfort
earli
wean
ventilatori
support
copd
progress
diseas
character
long
preclin
phase
gradual
declin
lung
function
year
patient
becom
symptomat
patient
experi
abrupt
perman
loss
lung
function
acut
exacerb
possibl
predict
clinic
cours
individu
patient
copd
variabl
diseas
limit
studi
examin
clinic
predictor
studi
observ
howev
acceler
declin
lung
function
heavi
current
smoker
patient
mucu
hypersecret
low
function
statu
airway
hyperreact
polymorph
tnfa
gene
promot
region
elev
level
fibrinogen
prognosi
patient
hospit
acut
exacerb
associ
hypercapnia
poor
term
surviv
postdischarg
healthrel
qualiti
life
prognosi
determin
sever
underli
copd
factor
associ
hospit
patient
admit
acut
exacerb
requir
rehospit
within
month
mortal
patient
hospit
acut
exacerb
mortal
climb
patient
requir
icu
admiss
mortal
patient
discharg
acut
exacerb
respect
six
month
discharg
patient
aliv
abl
report
good
good
excel
qualiti
life
disabl
symptom
dyspnea
import
factor
decreas
qualiti
life
view
poor
longterm
prognosi
term
surviv
qualiti
life
risk
stratif
model
identifi
patient
high
risk
inpati
death
poor
postdischarg
outcom
would
assist
patient
select
intub
niewoehn
et
al
observ
fev
admiss
first
sever
day
hospit
highli
associ
clinic
outcom
patient
requir
intub
mechan
ventil
comorbid
acut
ill
sever
score
predict
surviv
requir
mechan
ventil
beyond
hour
extub
follow
reintub
associ
high
mortal
connor
et
al
report
data
studi
understand
prognos
prefer
outcom
risk
treatment
found
independ
associ
sever
ill
score
bodi
mass
index
older
age
prior
function
statu
sever
hypoxia
congest
heart
failur
serum
albumin
presenc
cor
pulmonal
surviv
almagro
et
al
recent
report
qualiti
life
marit
statu
depress
symptom
comorbid
prior
hospit
admiss
identifi
hospit
patient
poor
postdischarg
surviv
unfortun
none
model
success
identifi
individu
patient
greater
likelihood
die
moreov
predict
model
valid
independ
cohort
consequ
exist
system
predict
inpati
mortal
postdischarg
function
capac
suitabl
select
patient
institut
continu
withdraw
lifesustain
therapi
palli
endoflif
care
icu
patient
advanc
copd
want
make
decis
regard
lifesupport
care
either
commun
physician
directli
appoint
surrog
instrument
advanc
care
plan
make
inform
decis
howev
patient
need
understand
natur
lifesupport
intervent
probabl
differ
outcom
life
intervent
use
respiratori
failur
unfortun
elderli
patient
moder
sever
copd
discuss
primari
care
physician
appropri
lifesupport
care
natur
intub
mechan
ventil
advanc
care
plan
occur
outpati
set
discuss
regard
appropri
lifesustain
care
take
place
hospit
acut
exacerb
ideal
primari
physician
know
patient
intim
initi
discuss
term
captainci
often
howev
primari
care
physician
avail
discuss
endoflif
care
hospit
icu
requir
critic
care
physician
serv
role
discuss
endoflif
care
critic
care
physician
need
inform
patient
famili
anticip
valu
lifesupport
care
adopt
howev
broader
approach
advanc
care
plan
incorpor
patient
perspect
physician
icu
often
focu
discuss
regard
lifesustain
intervent
appli
variou
clinic
circumst
patient
famili
howev
overarch
goal
pertain
prepar
death
achiev
sens
control
secur
person
relationship
friend
famili
patient
termin
copd
orient
toward
psycholog
emot
spiritu
need
discuss
may
shift
patient
physician
discuss
use
lifesupport
intervent
patient
famili
friend
commun
fortifi
relationship
share
decis
lifesupport
care
mutual
support
patient
acut
exacerb
choos
forego
lifesupport
care
withdrawn
need
relief
pain
suffer
expert
manag
endoflif
care
also
benefit
reassur
physician
nurs
back
away
care
disabl
symptom
cough
dyspnea
anxieti
depress
typic
complic
termin
cours
patient
die
copd
patient
termin
stage
copd
choos
use
ventil
support
use
timelimit
span
sure
compet
relief
terrifi
dyspnea
copd
progress
disord
punctuat
later
stage
acut
exacerb
present
risk
respiratori
failur
copd
disproportion
impact
older
patient
icu
therapi
direct
toward
unload
fatigu
respiratori
muscl
treat
airway
infect
prescrib
bronchodilatori
drug
patient
surviv
hospit
icu
episod
respiratori
failur
sever
underli
lung
diseas
howev
underli
poor
outcom
patient
term
postdischarg
surviv
qualiti
life
